Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Beijing

    Main Sales Markets: Central/South America,Western Europe,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: T/T

    Strength: 0.4g

    Indications:

    Sofosbuvir is indicated for the treatment of chronic Genotype 2 hepatitis C virus (HCV) in adults as used in combination with ribavirin.

    Sofosbuvir in combination with Coblopasvir hydrochloride is indicated for the treatment of HCV Genotypes 1, 2, 3 and 6 infections, complicated by compensatory cirrhosis or not, in naive adult patients or patients previously treated with interferons.

Send your message to this supplier
  • From:
  • To:
    Beijing Kawin Technology Share-Holding Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service